Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P06889 (
Mol
)
630,302
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The semaphorins/collapsins constitute a family of genes unified by the presence of a "semaphorin domain" which has been conserved through metazoan evolution. The semaphorin family comprises both secreted and transmembrane molecules and is thought to be made up of ligands for as yet unidentified receptors. The functions are not known, with the exception of those of sema III (also referred as sem D and collapsin 1), D-sema I, and D-sema II, which have been shown to be involved in axonal pathfinding. Here report the identification of a mouse semaphorin cDNA, termed
Sema VIb
. Although
Sema VIb
contains the extracellular semaphorin domain, it lacks the immunoglobulin domain or thrombospondin repeats which are present in other described vertebrate (but not invertebrate) transmembrane semaphorins. During development
Sema VIb
mRNA is expressed in subregions of the nervous system and is particularly prominent in muscle. In adulthood,
Sema VIb
mRNA is expressed ubiquitously. The cytoplasmic domain of
Sema VIb
contains several proline-rich potential SH3 domain binding sites. Using an in vitro binding assay, we show that
Sema VIb
binds specifically the SH3 domain of the protooncogene c-src. In transfected COS cells
Sema VIb
coimmunoprecipitates with c-src. These results, along with our evidence that
Sema VIb
can form dimers, suggests that the semaphorin family not only serves as ligands but may include members, especially those which are transmembrane, which serve as receptors, triggering intracellular signaling via an src-related cascade.
Mol
Cell Neurosci 1997
PMID:A novel transmembrane semaphorin can bind c-src. 936 Dec 78
Semaphorins/collapsins (semaphorins) comprise a large family of proteins implicated in axonal guidance during development. We cloned a novel member (
semaZ
) of the semaphorin gene family from a rat brain cDNA library. Sema Z was thought to be an integral membrane glycoprotein of 887 amino acids including a sema domain composed of 532 amino acids. The amino acid sequence of Sema Z showed 28-35% identity with other semaphorins in its sema domain, including 15 conserved cysteine residues. The cytoplasmic domain of Sema Z was found to be rich in prolines. Our phylogenetic analysis based on the amino acid sequence of the sema domains and the location of conserved N-glycosylation sites suggested that the sema domain of Sema Z belongs to a new class, class VI. We detected the
semaZ
mRNA in the first branchial arch of embryonic day 11 (E11) rat embryo, and subsequently in the myotomes and the dorsal root ganglia in developing somites from E11.5 through E13.5, but not in the brain. However, at E15, 18, 21 and P0,
semaZ
was highly expressed in the brain. Sema Z might play a role in both peripheral and central nervous system development.
Brain Res
Mol
Brain Res 1997 Nov
PMID:Molecular cloning of a novel member of semaphorin family genes, semaphorin Z. 942 25